ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $799,000 | -19.5% | 11 | 0.0% | 0.00% | – |
| Q3 2021 | $992,000 | +3.0% | 11 | 0.0% | 0.00% | – |
| Q2 2021 | $963,000 | -23.1% | 11 | 0.0% | 0.00% | – |
| Q1 2021 | $1,252,000 | -17.8% | 11 | 0.0% | 0.00% | – |
| Q4 2020 | $1,523,000 | +68.5% | 11 | 0.0% | 0.00% | – |
| Q3 2020 | $904,000 | +5.1% | 11 | 0.0% | 0.00% | – |
| Q2 2020 | $860,000 | +75.9% | 11 | 0.0% | 0.00% | – |
| Q1 2020 | $489,000 | -27.1% | 11 | 0.0% | 0.00% | – |
| Q4 2019 | $671,000 | +42.8% | 11 | 0.0% | 0.00% | – |
| Q3 2019 | $470,000 | -32.7% | 11 | 0.0% | 0.00% | – |
| Q2 2019 | $698,000 | -99.4% | 11 | -99.3% | 0.00% | -100.0% |
| Q1 2019 | $111,002,000 | +212.2% | 1,601 | +95.7% | 0.02% | +266.7% |
| Q4 2018 | $35,556,000 | – | 818 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |